2013 Hematology and Medical Oncology Best Practices Brochure
2013 Hematology and Medical Oncology Best Practices Brochure
2013 Hematology and Medical Oncology Best Practices Brochure
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>2013</strong> <strong>Hematology</strong> <strong>and</strong><br />
<strong>Medical</strong> <strong>Oncology</strong><br />
<strong>Best</strong> <strong>Practices</strong><br />
August 15 – 22, <strong>2013</strong><br />
<strong>Hematology</strong> only: August 15-19<br />
<strong>Medical</strong> <strong>Oncology</strong> only: August 18-22<br />
NEW<br />
REDUCED<br />
RATES<br />
Crystal Gateway Marriott<br />
Arlington, VA<br />
Course Director: <br />
Robert S. Siegel, M.D.<br />
www.HemOnc<strong>Best</strong><strong>Practices</strong>.com
<strong>2013</strong> <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong><br />
<strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong><br />
The <strong>2013</strong> <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong> course is a five- or<br />
eight-day comprehensive review of clinical best practices presented by the nation’s<br />
leading clinicians <strong>and</strong> educators in the field.<br />
Whether you are preparing for the certification/recertification exams, or simply<br />
seeking a comprehensive review of evidence-based st<strong>and</strong>ards of care, you can<br />
benefit from Course Director Robert S. Siegel’s 20+ years of experience producing<br />
<strong>and</strong> refining this course.<br />
***<strong>2013</strong> Tuition fees have been reduced by $200.***<br />
<strong>Hematology</strong> Only<br />
(August 15-19, <strong>2013</strong>)<br />
<strong>Medical</strong> <strong>Oncology</strong> Only<br />
(August 18-22, <strong>2013</strong>)<br />
<strong>Hematology</strong> & <strong>Medical</strong> <strong>Oncology</strong><br />
(August 15-22, <strong>2013</strong>)<br />
Early Bird<br />
Regular<br />
Post Marked by June 15, <strong>2013</strong> Post Marked after June 15, <strong>2013</strong><br />
Physician<br />
Fellow, Resident<br />
Physician<br />
Fellow, Resident<br />
& Other<br />
& Other<br />
$1,395 $1,195 $1,545 $1,345<br />
$1,395 $1,195 $1,545 $1,345<br />
$2,025 $1,895 $2,175 $2,045<br />
For information <strong>and</strong> to register, visit www.HemOnc<strong>Best</strong><strong>Practices</strong>.com.<br />
ACCREDITATION<br />
The George Washington University School of Medicine<br />
<strong>and</strong> Health Sciences is accredited by the Accreditation<br />
Council for Continuing <strong>Medical</strong> Education to provide<br />
continuing medical education for physicians.<br />
Physician CME Credit for 8-day<br />
<strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong><br />
section<br />
The George Washington University School of Medicine<br />
<strong>and</strong> Health Sciences designates this live activity for a<br />
maximum of 72.5 AMA Physician Recognition Award<br />
Category 1 Credits. Physicians should claim only the<br />
credit commensurate with the extent of their participation<br />
in the activity.<br />
Physician CME Credit for 5-day<br />
<strong>Hematology</strong> section<br />
The George Washington University School of Medicine<br />
<strong>and</strong> Health Sciences designates this live activity for a<br />
maximum of 46.75 AMA Physician Recognition Award<br />
Category 1 Credits. Physicians should claim only the<br />
credit commensurate with the extent of their participation<br />
in the activity.<br />
Physician CME Credit for 5-day<br />
<strong>Medical</strong> <strong>Oncology</strong> section<br />
The George Washington University School of Medicine<br />
<strong>and</strong> Health Sciences designates this live activity for a<br />
maximum of 46.5 AMA Physician Recognition Award<br />
Category 1 Credits. Physicians should claim only the<br />
credit commensurate with the extent of their participation<br />
in the activity.<br />
At the close of the course, participants will be e-mailed a link to evaluate the course, claim credit, <strong>and</strong> print a certificate.<br />
2 <strong>2013</strong> <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong>
COURSE DIRECTOR AND FACULTY<br />
COURSE DIRECTORS<br />
Robert S. Siegel, M.D.<br />
The George Washington University<br />
GUEST FACULTY<br />
Amy P. Abernethy, M.D.<br />
Duke University<br />
David J. Adelstein, M.D.<br />
Case Western Reserve University<br />
Dean F. Bajorin, M.D.<br />
Weil <strong>Medical</strong> College of Cornell<br />
University<br />
Kenneth A. Bauer, M.D.<br />
Harvard University<br />
Nancy Berliner, M.D.<br />
Harvard University<br />
Charles D. Bolan, M.D.*<br />
Edward Chu, M.D.<br />
University of Pittsburgh<br />
Daniel L. Clarke-Pearson, M.D.<br />
University of North Carolina,<br />
Chapel Hill<br />
Nancy E. Davidson, M.D.<br />
University of Pittsburgh<br />
Howard A. Fine, M.D.<br />
New York University<br />
Judy E. Garber, M.D.<br />
Harvard University<br />
Morie A. Gertz, M.D.<br />
Mayo Clinic Rochester<br />
Victor R. Gordeuk, M.D.<br />
University of Illinois<br />
Ann Gramza, M.D.*<br />
Daniel G. Haller, M.D.<br />
University of Pennsylvania<br />
David H. Ilson, M.D., Ph.D.<br />
Weill <strong>Medical</strong> College of<br />
Cornell University<br />
Claudine Isaacs, M.D.<br />
Georgetown University<br />
Bruce E. Johnson, M.D.<br />
Harvard University<br />
Hagop Kantarjian, M.D.<br />
The University of Texas MD<br />
Anderson Cancer Center<br />
Philip Kantoff, M.D.<br />
Harvard University<br />
Gregory J. Kato, M.D.*<br />
Nigel S. Key, M.D.<br />
University of North Carolina,<br />
Chapel Hill<br />
Thomas S. Kickler, M.D.<br />
Johns Hopkins University<br />
Hedy Lee Kindler, M.D.<br />
University of Chicago<br />
Patrick J. Loehrer, Sr., M.D.<br />
Indiana University<br />
John S. Macdonald, M.D.<br />
New York <strong>Medical</strong> College<br />
B. Gail Macik, M.D.<br />
University of Virginia Health System<br />
John L. Marshall, M.D.<br />
Georgetown University<br />
L. Jeffrey Medeiros, M.D.<br />
The University of Texas MD<br />
Anderson Cancer Center<br />
Susan O’Brien, M.D.<br />
The University of Texas MD<br />
Anderson Cancer Center<br />
S. Vincent Rajkumar, M.D.<br />
Mayo Clinic Rochester<br />
A. Koneti Rao, M.D.<br />
Temple University<br />
Margaret E. Rick, M.D.<br />
Uniformed Services University of<br />
the Health Sciences<br />
Jerry L. Spivak, M.D.<br />
Johns Hopkins University School<br />
of Medicine<br />
David P. Steensma, M.D.<br />
Harvard University<br />
F. Marc Stewart, M.D.<br />
University of Washington<br />
Ayalew A. Tefferi, M.D.<br />
Mayo Clinic Rochester<br />
James (Tate) Thigpen, M.D.<br />
University of Mississippi<br />
<strong>Medical</strong> Center<br />
Julie M. Vose, M.D., M.B.A.<br />
University of Nebraska<br />
Theodore (Ted) E. Warkentin, M.D.<br />
McMaster University<br />
Hamilton, Ontario, Canada<br />
The George<br />
Washington<br />
University School<br />
of Medicine <strong>and</strong><br />
Health Sciences<br />
Faculty<br />
James D. Ahlgren, M.D.<br />
Jeanny B. Aragon-Ching, M.D.<br />
Donald S. Karcher, M.D.<br />
Vera Malkovska, M.D.<br />
Imad A. Tabbara, M.D.<br />
Bernhard L. (Bud) Wiedermann, M.D.<br />
*Individual employees of the National Institutes of Health (NIH) have participated in the planning <strong>and</strong> development of the course, although the NIH is not<br />
an official sponsor. The views expressed by the participants do not necessarily represent the opinions of the NIH, DHHS, or the Federal Government.<br />
In accordance with the Accreditation Council for Continuing <strong>Medical</strong> Education’s St<strong>and</strong>ards for Commercial<br />
Support, The George Washington University Office of CEHP requires that all individuals involved in the<br />
development of activity content disclose their relevant financial relationships <strong>and</strong> that all conflicts of interest be<br />
identified, resolved, <strong>and</strong> communicated to the learners prior to delivery of the activity.<br />
August 15 – 22, <strong>2013</strong> • Crystal Gateway Marriott, Arlington, VA 3
Agenda<br />
Thursday, August 15, <strong>2013</strong> Friday, August 16, <strong>2013</strong><br />
<strong>Hematology</strong>: Day 1<br />
(Hem & HemOnc Participants)<br />
7:00 AM On-Site Registration<br />
8:00 AM Biology of Hematopoiesis<br />
Jerry L. Spivak, M.D.<br />
9:00 AM Iron Deficiency <strong>and</strong> Overload<br />
Victor R. Gordeuk, M.D.<br />
10:00 AM Refreshment Break<br />
10:15 AM Prothrombotic Complications<br />
of Anticoagulation<br />
Theodore (Ted) E. Warkentin, M.D.<br />
11:15 AM Consumptive<br />
Thrombohemorrhagic Disorders<br />
Theodore (Ted) E. Warkentin, M.D.<br />
11:45 AM Lunch (provided)<br />
12:05 PM Lunch Review Session:<br />
Anemias, TTP, HIT, <strong>and</strong><br />
Sickle Cell Disease<br />
Drs. Kato, Gordeuk, Siegel, <strong>and</strong> Warkentin<br />
1:45 PM Problems in Hemostaisis <strong>and</strong><br />
Thrombosis<br />
Drs. Siegel <strong>and</strong> Warkentin<br />
2:15 PM RBC Enzymes, Membranes, <strong>and</strong><br />
Metabolism<br />
Imad A. Tabbara, M.D.<br />
3:00 PM Refreshment Break<br />
3:15 PM Hemoglobinopathies<br />
Victor R. Gordeuk, M.D.<br />
4:15 PM Sickling Disorder<br />
Gregory J. Kato, M.D.<br />
5:15 PM Porphyria<br />
5:45 PM Adjourn<br />
<strong>Hematology</strong>: Day 2<br />
(Hem & HemOnc Participants)<br />
7:00 AM On-Site Registration<br />
8:00 AM Mechanisms for Clotting<br />
Nigel S. Key, M.D.<br />
8:35 AM The Hemophilias<br />
Nigel S. Key, M.D.<br />
9:20 AM Von Willebr<strong>and</strong>’s Disease<br />
Margaret Rick, M.D.<br />
10:05 AM Refreshment Break<br />
10:20 AM Acquired Disorders of Coagulation<br />
Margaret Rick, M.D.<br />
11:05 AM White Cell Disorders<br />
Nancy Berliner, M.D.<br />
12:00 PM Lunch (provided)<br />
12:20 PM Lunch Review Session: WBC Disorders<br />
<strong>and</strong> Coagulopathy<br />
Drs. Bauer, Berliner, Macik, Siegel, <strong>and</strong> Rao<br />
2:00 PM Hypercoagulable States<br />
Kenneth A. Bauer, M.D.<br />
3:00 PM Qualitative Platelet Defects<br />
A. Koneti Rao, M.D.<br />
3:45 PM Refreshment Break<br />
4:00 PM Oral Anticoagulants <strong>and</strong><br />
Antithrombotic Therapy<br />
B. Gail Macik, M.D.<br />
5:00 PM Parenteral Antithrombotics <strong>and</strong><br />
Thrombolytic Therapy<br />
B. Gail Macik, M.D.<br />
5:30 PM Adjourn<br />
4 <strong>2013</strong> <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong>
Saturday, August 17, <strong>2013</strong> Sunday, August 18, <strong>2013</strong><br />
<strong>Hematology</strong>: Day 3<br />
(Hem & HemOnc Participants)<br />
7:00 AM On-Site Registration<br />
8:00 AM ITP <strong>and</strong> Drug Induced Thrombocytopenias<br />
Robert S. Siegel, M.D.<br />
8:45 AM Transfusion Medicine<br />
Thomas S. Kickler, M.D.<br />
9:40 AM Refreshment Break<br />
9:55 AM Platelet Alloimmunization<br />
Thomas S. Kickler, M.D.<br />
10:30 AM Aplastic Anemia<br />
11:30 AM Anemia of Chronic Illness<br />
Vera Malkovska, M.D.<br />
12:15 PM Lunch (provided)<br />
12:35 PM Lunch Review Session:<br />
Thrombocytopenias, Aplastic Anemia,<br />
Anemias, <strong>and</strong> Myeloproliferative Disease<br />
Drs. Kickler, Malkovska, Siegel, <strong>and</strong> Tefferi<br />
2:15 PM Megaloblastic <strong>and</strong> Sideroblastic Anemias<br />
Vera Malkovska, M.D.<br />
3:00 PM Hemolytic Anemias<br />
Imad A. Tabbara, M.D.<br />
3:45 PM Refreshment Break<br />
4:00 PM Hematologic Complications of Pregnancy<br />
Robert S. Siegel, M.D.<br />
4:45 PM Myeloproliferative Neoplasms<br />
Ayalew A. Tefferi, M.D.<br />
3:00 PM – On-Site Registration for<br />
6:00 PM <strong>Medical</strong> <strong>Oncology</strong> Only<br />
6:15 PM Adjourn<br />
All participants are welcome to attend the<br />
Myeloproliferative Neoplasms session.<br />
Hematologic Malignancies:<br />
Day 1 (All Participants)<br />
7:00 AM On-Site Registration<br />
7:45 AM Pathology of Lymphomas<br />
L. Jeffrey Medeiros, M.D.<br />
8:45 AM Non-Hodgkin’s Lymphoma<br />
Julie M. Vose, M.D., M.B.A.<br />
9:45 AM Refreshment Break<br />
10:00 AM Hodgkin’s Disease<br />
Julie M. Vose, M.D., M.B.A.<br />
10:45 AM Chronic Lymphocytic Leukemia<br />
Susan O’Brien, M.D.<br />
11:30 AM Acute Lymphocytic Leukemia<br />
Hagop Kantarjian, M.D.<br />
12:00 PM Lunch (provided)<br />
12:20 PM Lunch Review Session:<br />
Lymphomas, CLL, ALL,<br />
CML, Plasma Cell Disorders,<br />
<strong>and</strong> M.D.S.<br />
Drs. Kantarjian, Steensma, O’Brien,<br />
Rajkumar, Vose, <strong>and</strong> Siegel<br />
2:00 PM Chronic Myeloid Leukemia<br />
Hagop Kantarjian, M.D.<br />
2:45 PM Multiple Myeloma,<br />
Plasmacytoma, MGUS<br />
S. Vincent Rajkumar, M.D.<br />
3:45 PM Myelodysplasia<br />
David P. Steensma, M.D.<br />
4:30 PM Refreshment Break<br />
4:45 PM Waldenstom’s<br />
Macroglobulinemia <strong>and</strong><br />
Amyloidosis<br />
Morie A. Gertz, M.D.<br />
5:30 PM Morphology Review<br />
Donald S. Karcher, M.D.<br />
6:15 PM Adjourn<br />
August 15 – 22, <strong>2013</strong> • Crystal Gateway Marriott, Arlington, VA 5
Agenda (cont.)<br />
Monday, August 19, <strong>2013</strong><br />
Hematologic Malignancies:<br />
Day 2 (all Participants)<br />
7:00 AM On-Site Registration<br />
8:00 AM Acute Myeloid Leukemia<br />
Imad A. Tabbara, M.D.<br />
9:00 AM Bone Marrow Transplantation<br />
F. Marc Stewart, M.D.<br />
10:15 AM Refreshment Break<br />
10:30 AM ABO Incompatibility <strong>and</strong> Other<br />
Transfusion-Related Issues in<br />
Hematopoietic Transplantation<br />
Charles D. Bolan, M.D.<br />
11:15 AM Pharmacology I<br />
Edward Chu, M.D.<br />
12:15 PM Lunch (provided)<br />
12:35 PM Lunch Review Session: AML,<br />
Pharmacology, <strong>and</strong> BMT<br />
Drs. Chu, Siegel, Stewart, <strong>and</strong> Tabbara<br />
2:15 PM Pharmacology II<br />
Edward Chu, M.D.<br />
3:00 PM Pharmacology III<br />
Edward Chu, M.D.<br />
3:30 PM Refreshment Break<br />
3:45 PM Melanoma<br />
4:30 PM Preparing for the Boards<br />
Bernhard (Bud) L. Wiedermann, M.D.<br />
5:15 PM Cancer in the Elderly<br />
TBD<br />
6:15 PM Adjourn -<br />
Close of <strong>Hematology</strong> Section<br />
tuesday, August 20, <strong>2013</strong><br />
<strong>Medical</strong> <strong>Oncology</strong>: Day 1<br />
(onc & HemOnc Participants only)<br />
7:00 AM On-Site Registration<br />
7:45 AM Head <strong>and</strong> Neck Cancer<br />
David J. Adelstein, M.D.<br />
8:45 AM Familial Cancer Syndromes<br />
Judy E. Garber, M.D., M.P.H.<br />
9:30 AM Small Cell Lung Cancer<br />
Bruce E. Johnson, M.D.<br />
10:15 AM Refreshment Break<br />
10:30 AM Non-Small Cell Lung Cancer<br />
Bruce E. Johnson, M.D.<br />
11:20 AM Adjuvant Therapy for Breast Cancer<br />
Nancy E. Davidson, M.D.<br />
12:15 PM Lunch (provided)<br />
12:35 PM Lunch Review Session: Breast Cancer,<br />
Lung Cancer, <strong>and</strong> Neuro-<strong>Oncology</strong><br />
Drs. Davidson, Fine, Isaacs, <strong>and</strong> Siegel<br />
2:15 PM Metastatic Breast Cancer<br />
Claudine Isaacs, M.D.<br />
3:00 PM Expert Panel: Problems in Treating<br />
Breast Cancer<br />
Drs. Davidson, Isaacs, <strong>and</strong> Siegel<br />
3:30 PM Refreshment Break<br />
3:45 PM Neuro-oncology<br />
Howard A. Fine, M.D.<br />
4:45 PM Metastatic Disease to the Brain, Spine,<br />
Carcinomatous Meningitis<br />
Howard A. Fine, M.D.<br />
5:15 PM Endocrine Malignancies<br />
Ann Gramza, M.D.<br />
6:00 PM Adjourn<br />
6 <strong>2013</strong> <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong>
Wednesday, August 21, <strong>2013</strong><br />
medical <strong>Oncology</strong>: Day 2 (Onc<br />
<strong>and</strong> HemOnc Participants only)<br />
7:00 AM On-Site Registration<br />
7:45 AM Testicular Cancer <strong>and</strong> Mediastinal<br />
Germ Cell Tumors<br />
Patrick J. Loehrer, Sr., M.D.<br />
8:30 AM Renal Cell Cancer<br />
Dean F. Bajorin, M.D.<br />
9:15 AM Prostate Cancer<br />
Philip Kantoff, M.D.<br />
10:15 AM Refreshment Break<br />
10:30 AM Bladder Cancer<br />
Dean F. Bajorin, M.D.<br />
11:00 AM Ovarian Cancer<br />
James (Tate) Thigpen, M.D.<br />
12:00 PM Lunch (provided)<br />
12:20 PM Lunch Review Session: GU, GYN<br />
<strong>and</strong> GI Tumors<br />
Drs. Aragon-Ching, Loehrer, Bajorin,<br />
Kindler, Thigpen, <strong>and</strong> Siegel<br />
2:00 PM Endometrial Cancer<br />
James (Tate) Thigpen, M.D.<br />
2:30 PM Cancer of the Cervix, Vulva, Vagina<br />
<strong>and</strong> Gestational Trophoblastic<br />
Tumors<br />
Daniel L. Clarke-Pearson, M.D.<br />
3:30 PM Esophageal Cancer<br />
David H. Ilson, M.D., M.P.H.<br />
4:15 PM Refreshment Break<br />
4:30 PM Pancreatic Cancer<br />
Hedy Lee Kindler, M.D.<br />
5:15 PM Mesothelioma<br />
Hedy Lee Kindler, M.D.<br />
5:45 PM Adjourn<br />
thursday, August 22, <strong>2013</strong><br />
medical <strong>Oncology</strong>: Day 3 (Onc <strong>and</strong><br />
HemOnc Participants only)<br />
7:00 AM On-Site Registration<br />
7:30 AM Carcinoid Tumors, Carcinoid Syndrome<br />
<strong>and</strong> Pancreatic Neuroendocrine Tumors<br />
James D. Ahlgren, M.D.<br />
8:00 AM Gastric Cancer<br />
John S. Macdonald, M.D.<br />
8:45 AM Metastatic Colon <strong>and</strong> Rectal Cancer<br />
John L. Marshall, M.D.<br />
9:30 AM Refreshment Break<br />
9:45 AM Hepatobiliary Cancer<br />
Daniel G. Haller, M.D.<br />
10:30 AM Anal Cancer<br />
John S. Macdonald, M.D.<br />
11:00 AM Adjuvant Therapy for Colon <strong>and</strong><br />
Rectal Cancer<br />
Daniel G. Haller, M.D.<br />
12:00 PM Lunch (provided)<br />
12:20 PM Lunch Review Session: GI, Sarcoma,<br />
<strong>and</strong> Palliative Care<br />
Drs. Abernethy, Aragon-Ching, Haller,<br />
Macdonald, <strong>and</strong> Siegel<br />
1:30 PM Sarcomas<br />
Jeanny B. Aragon-Ching,M.D.<br />
2:15 PM Palliative Care<br />
Amy P. Abernethy, M.D.<br />
3:00 PM Adjourn -<br />
Close of <strong>Hematology</strong> <strong>and</strong><br />
<strong>Medical</strong> <strong>Oncology</strong> Sections<br />
*Agenda is subject to change.<br />
August 15 – 22, <strong>2013</strong> • Crystal Gateway Marriott, Arlington, VA 7
The Office of Continuing Education in the Health Professions<br />
The School of Medicine & Health Sciences<br />
The George Washington University<br />
2030 M Street NW, Room 4020<br />
Washington, DC 20036<br />
1-800-314-1423<br />
cehp@gwu.edu<br />
U.S. Postage<br />
PAID<br />
Hagerstown, MD<br />
Permit No. 93<br />
Meeting Location <strong>and</strong><br />
Hotel Accommodations:<br />
Crystal Gateway Marriott (New Hotel)<br />
1700 Jefferson Davis Highway<br />
Arlington, VA 22202-3505<br />
703-920-3230<br />
$159 per night Room Rate!<br />
Our special event room rate is $159 per night (single occupancy) plus tax.<br />
This rate will be offered until our room block is full or until Monday, July 15,<br />
<strong>2013</strong>. The room rate also covers access to the fitness center <strong>and</strong> in-guest<br />
room internet.<br />
Reservations can be made by:<br />
• Calling 1-888-236-2427 <strong>and</strong> referencing the <strong>2013</strong> George Washington<br />
University <strong>Hematology</strong> <strong>and</strong> <strong>Medical</strong> <strong>Oncology</strong> <strong>Best</strong> <strong>Practices</strong> Review Course<br />
• Visiting the Reservation website at http://tinyurl.com/cx9n37p<br />
For more information, visit the Hotel Section of the course website<br />
www.HemOnc<strong>Best</strong><strong>Practices</strong>.com
Change language